Related references
Note: Only part of the references are listed.Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring
Feng Xu et al.
ANNALS OF HEMATOLOGY (2011)
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
Qing Li et al.
BLOOD (2011)
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
Damian B. Yap et al.
BLOOD (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies
Matthew R. Warr et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2011)
Polycomb proteins in hematologic malignancies
Daniel Martin-Perez et al.
BLOOD (2010)
Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML
Thomas A. Paul et al.
BLOOD (2010)
Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
Ann Mullally et al.
CANCER CELL (2010)
miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal
Antonio Herrera-Merchan et al.
CELL CYCLE (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization
S. Goyama et al.
LEUKEMIA (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Molecular Signatures of Quiescent, Mobilized and Leukemia-Initiating Hematopoietic Stem Cells
E. Camilla Forsberg et al.
PLOS ONE (2010)
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Christopher J. Sneeringer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulating the leukaemia stem cell
Michael L. Cleary
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
Warren Fiskus et al.
BLOOD (2009)
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Adrian P. Bracken et al.
NATURE REVIEWS CANCER (2009)
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells
Winnie F. Tam et al.
BLOOD (2008)
Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs
Susana Gonzalez et al.
CELL CYCLE (2008)
Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells
Susumu Goyama et al.
CELL STEM CELL (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance
Mark J. Kiel et al.
CELL STEM CELL (2007)
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells
Adrian P. Bracken et al.
GENES & DEVELOPMENT (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Epigenetic stem cell signature in cancer
Martin Widschwendter et al.
NATURE GENETICS (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
Joyce E. Ohm et al.
NATURE GENETICS (2007)
Oncogenes in myeloproliferative disorders
Ayalew Tefferi et al.
CELL CYCLE (2007)
Hematopoietic stem cell self-renewal
Omobolaji O. Akala et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
被撤回的出版物: Oncogenic activity of Cdc6 through repression of the INK4/ARF locus (Retracted article. See vol. 547, pg. 246, 2017)
S Gonzalez et al.
NATURE (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates
E Passegué et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis
BA Croker et al.
IMMUNITY (2004)
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder
BS Braun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche
F Arai et al.
CELL (2004)
Polycomb complexes and silencing mechansims
AH Lund et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Transgenic mice with hematopoietic and lymphoid specific expression of Cre
J de Boer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice
SC Kogan et al.
BLOOD (2002)
Share Paper
